Viral vector demand still exceeds capacity, according to analysts who say biopharma firms and CDMOs need new facilities and more efficient production processes. Industry concerns about vector supplies ...

Opinions expressed by Entrepreneur contributors are their own. Businesses often follow a define-plan-execute method of problem solving: spend time up front rigorously defining a problem, develop a ...